Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 6.89%
March 31, 2026 7.98%
December 31, 2025 7.65%
September 30, 2025 8.03%
June 30, 2025 7.30%
March 31, 2025 8.11%
December 31, 2024 8.13%
September 30, 2024 8.33%
June 30, 2024 7.44%
March 31, 2024 8.15%
December 31, 2023 7.71%
September 30, 2023 8.08%
June 30, 2023 7.08%
March 31, 2023 8.09%
December 31, 2022 7.52%
September 30, 2022 8.39%
June 30, 2022 7.03%
March 31, 2022 7.98%
December 31, 2021 7.18%
September 30, 2021 8.16%
June 30, 2021 6.31%
March 31, 2021 7.66%
December 31, 2020 7.24%
September 30, 2020 8.31%
June 30, 2020 6.45%
Date Value
March 31, 2020 9.44%
December 31, 2019 8.51%
September 30, 2019 9.18%
June 30, 2019 7.97%
March 31, 2019 9.27%
December 31, 2018 8.81%
September 30, 2018 9.84%
June 30, 2018 7.61%
March 31, 2018 9.18%
December 31, 2017 8.85%
September 30, 2017 8.93%
June 30, 2017 8.36%
March 31, 2017 9.51%
December 31, 2016 9.20%
September 30, 2016 9.49%
June 30, 2016 8.15%
March 31, 2016 9.74%
December 31, 2015 9.04%
September 30, 2015 9.10%
June 30, 2015 8.39%
March 31, 2015 9.07%
December 31, 2014 9.34%
September 30, 2014 9.44%
June 30, 2014 8.59%
March 31, 2014 10.04%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Medipal Holdings Corp. 6.29%
Vital KSK Holdings, Inc. 8.03%
Cencora, Inc. 3.93%
Cardinal Health, Inc. 3.87%
McKesson Corp. 3.31%